Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms

Journal of Biochemistry

Volumn 151, Issue 5, 2012, Pages 493-499

  Bellini, Tiziana ^a   Trentini, Alessandro ^a   Manfrinato, Maria C ^a   Tamborino, Carmine ^a   Volta, Carlo Alberto ^a   Di Foggia, Valentina ^a   Fainardi, Enrico ^b   Dallocchio, Franco ^a   Castellazzi, Massimiliano ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

activity assay; biological markers; metalloproteinase; MMP 9; zymography

Indexed keywords

GELATINASE A; GELATINASE B; HEMOPEXIN; ISOENZYME; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; BODY FLUID; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; FEMALE; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; PROTEIN DOMAIN; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; BODY FLUIDS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; REFERENCE VALUES; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84860463028     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvs014     Document Type: Article

References (25)

1. Massova, I., Kotra, L.P., Fridman, R., and Mobashery, S. (1998) Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 12, 1075-1095
2. Nagase, H., Visse, R., and Murphy, G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562-573
3. Lemaitre, V. and D'armiento, J. (2006) Matrix metalloproteinases in development and disease. Birth Defects Res. 78, 1-10
4. Sang, Q.X., Birkedal-Hansen, H., and Van Wart, H.E. (1995) Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim. Biophys. Acta 1251, 99-108
5. Lacraz, S., Nicod, L.P., Chicheportiche, R., Welgus, H.G., and Dayer, J.M. (1995) IL-10 inhibits metallopro-teinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest. 96, 2304-2310
6. Van den Steen, P.E., Dubois, B., Nelissen, I., Rudd, P.M., Dwek, R.A., and Opdenakker, G. (2002) Biochemistry and molecular biology of Gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536
7. Ardi, V.C., Kupriyanova, T.A., Deryugina, E.I., and Quigley, J.P. (2007) Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc. Natl Acad. Sci. USA 104, 20262-20267
8. Cuzner, M.L. and Opdenakker, G (1999) Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94, 1-14
9. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T. (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712-21719
10. Vempati, P., Karagiannis, E.D., and Popel, A.S. (2007) A biochemical model of Matrix Metalloproteinase 9 activation and inhibition. J. Biol. Chem. 282, 37585-37596
11. Ogata, Y., Enghild, J.J., and Nagase, H. (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267, 3581-3584
12. Murphy, G and Docherty, A.J. (1992) The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell. Mol. Biol. 7, 120-125
13. Birkedal-Hansen, H., Moore, W.G, Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A., and Engler, A. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 4, 197-250
14. O'Connell, J.P., Willenbrock, H.F., Docherty, A.J.P., Eaton, D., and Murphy, G (1994) Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity and tissue inhibitor of Metalloproteinase interactions of Gelatinase B. J. Biol. Chem. 269, 14967-14973
15. Fainardi, E., Castellazzi, M., Bellini, T., Manfrinato, M.C., Baldi, E., Casetta, I., Paolino, E., Granieri, E., and Dallocchio, F. (2006) Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult. Scler. 12, 294-301
16. Fainardi, E., Castellazzi, M., Bellini, T., and Dallocchio, F. (2007) Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies. Mult. Scler. 13, 691-692
17. Castellazzi, M., Tamborino, C, Fainardi, E., Manfrinato, M.C., Granieri, E., Dallocchio, F., and Bellini, T. (2007) Effects of anticoagulants on the activity of gelatinase. Clin. Biochem. 40, 1272-1276
18. Heussen, C. and Dowdle, E.B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymer-ized substrates. Anal. Biochem. 102, 196-202
19. Rantala-Ryhanen, S., Ryhanen, L., Nowak, F.V., and Uitto, J. (1983) Proteinases in human polymorpho-nuclear leukocytes. Purification and characterization of an enzyme which cleaves denatured collagen and a synthetic peptide with a Gly-Ile sequence. J. Biochem. 134, 129-237
20. Shapiro, S.D., Fliszar, C.J., Broekelmann, T.J., Mecham, R.P., Senior, R.M., and Welgus, H.G (1995) Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J. Biol. Chem. 270, 6351-6356
21. Grierson, C, Miller, D., LaPan, P., and Brady, J. (2010) Utility of combining MMP-9 enzyme-linked immuno-sorbent assay and MMP-9 activity assay data to monitor plasma enzyme specific activity. Anal Biochem. 404, 232-234
22. Hanemaaijer, R., Visser, H., Konttinen, Y.T., Koolwijk, P., and Verheijen, J.H. (1998) A novel and simple immu-nocapture assay for determination of Gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjogren's syndrome contain increased latent and active Gelatinase-B levels. Matrix Biol. 17, 657-665
23. Raitio, A., Tuomas, H., Kokkonen, N., Salo, T., Sorsa, T., Hanemaaijer, R., and Oikarinen, A. (2005) Levels of matrix metalloproteinase-2,-9 and-8 in the skin, serum and saliva of smokers and non-smokers. Arch. Dermatol. Res. 297, 242-248
24. Cha, H., Kopetzki, E., Huber, R., Lanzendorfer, M., and Brandstetter, H. (2002) Structural basis of the adaptive molecular recognition by MMP9. J. Mol. Biol. 320, 1065-1079
25. Shimizu, S., Ozawa, S., and Kubota, E. (2005) Activation of cancer cell-derived MMP-9 correlates with cancer invasion-an in vitro study with 3-dimensional co-culture system. Oral Med. Pathol. 10, 63-72